Trends in Prescription Drug Launch Prices

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, JUNE 7, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.5542?guestAccessKey=8f0b6984-7e44-45e4-b51e-19bde218c1be&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=060722

 

About The Study: Recent trends in prices for newly marketed brand-name prescription drugs in the United States from 2008 to 2021 were evaluated in this study.

Authors: Benjamin N. Rome, M.D., M.P.H., of Brigham and Women’s Hospital in Boston, is the corresponding author.

 

(doi:10.1001/jama.2022.5542)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.